Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SYBU |
| Upstream (Parents) |
|---|
| (<<) FCGR2A → SYBU |
| (<<) FCGR1B → SYBU |
| (<<) CLEC7A → SYBU |
| (<<) DFNA5 → SYBU |
| (<<) RASL11B → SYBU |
| (<<) SYT11 → SYBU |
| Downstream (Children) |
|---|
| SYBU → SLC7A8 (>>) |
| SYBU → EGF (>>) |
| SYBU → IL12B (>>) |
| SYBU → SLC27A6 (>>) |
| SYBU → KIR2DS2///KIR3DP1///LOC727787///KIR2DL5B///KIR3DP1///KIR3DL3///KIR2DL5A///KIR3DL2///KIR3DL1///KIR2DS5///KIR2DS4///KIR2DS3///KIR2DS1///KIR2DL3///KIR2DL2///KIR2DL1 (>>) |
| SYBU → UNC5C (>>) |
| SYBU → EFNB3 (>>) |
| SYBU → ABCA3 (>>) |
| SYBU → S100A13 (>>) |
| SYBU → ZDHHC11 (>>) |
| SYBU → EPB41L4B (>>) |
| SYBU → C11orf21 (>>) |
| SYBU → RASL11B (>>) |
